Skip to content

Evaluation of Balance and Physical Performance Under Dual Task Conditions in Individuals With and Without Generalized Joint Hypermobility

Evaluation of Balance and Physical Performance Under Dual Task Conditions in Individuals With and Without Generalized Joint Hypermobility

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07044999
Enrollment
2
Registered
2025-07-01
Start date
2025-07-01
Completion date
2025-08-01
Last updated
2025-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypermobility Syndrome

Brief summary

This study aims to evaluate balance and physical performance under dual task conditions in individuals with and without Generalized Joint Hypermobility (GJH), as determined by the Beighton score. All participants will undergo the One-Leg Stance Test and 30-Second Sit-to-Stand Test under both single-task (balance only) and dual-task (simultaneous cognitive task) conditions. The cognitive task will involve counting backward by sevens from a given number. Participants will also complete the Timed Up and Go (TUG) test under both single- and dual-task conditions. Additionally, the Berg Balance Scale (BBS) will be used for comprehensive balance assessment. Balance confidence will be evaluated using the Activities-specific Balance Confidence Scale (ABC-16), and fear of falling will be assessed with the Falls Efficacy Scale-International (FES-I). Changes in performance under dual-task conditions will be expressed as a percentage using the Dual Task Cost (DTC) formula

Interventions

OTHERno intervention

no intervention

Sponsors

Beylikduzu State Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years

Inclusion criteria

* Aged between 18 and 40 years * A Beighton score of 4 or higher (indicative of Generalized Joint Hypermobility) * Willingness to participate in the study

Exclusion criteria

* Younger than 18 or older than 40 years * Presence of neurological disorders (e.g., stroke, multiple sclerosis, peripheral neuropathy) * History of vestibular system disorders (e.g., benign paroxysmal positional vertigo, vestibular neuritis) * History of orthopedic conditions affecting the lower extremities (e.g., fracture, joint replacement, ligament injury) * Cognitive impairment preventing the execution of cognitive tasks * Diagnosis of systemic musculoskeletal diseases (e.g., rheumatoid arthritis, Ehlers-Danlos syndrome) * Pregnancy * Participation in balance training or neurological/physiotherapy programs within the last 6 months

Design outcomes

Primary

MeasureTime frameDescription
Performance in the One-Leg Stance Test0 dayAssesses static balance capacity and the impact of a simultaneous cognitive task on postural control.
Performance in the 30-Second Sit-to-Stand Test0 dayEvaluates lower extremity muscle endurance and functional strength under cognitive load
Performance in the Timed Up and Go (TUG) test0 dayMeasures dynamic balance, mobility, and the ability to maintain performance during divided attention.
Dual Task Cost (DTC) percentage0 dayQuantifies the percentage change in performance when a cognitive task is added, reflecting dual-task interference.

Secondary

MeasureTime frameDescription
Activities-specific Balance Confidence Scale (ABC-16)0 dayReflects the individual's perceived confidence in performing daily activities without losing balance.The maximum score is 100, the minimum score is 0. Higher scores indicate that high confidence patient's balance.
Falls Efficacy Scale-International (FES-I):0 dayAssesses fear of falling during daily life activities, indicating fall-related psychological concerns. Higher scores indicate that high degree fear of falling
Berg Balance Scale (BBS):0 dayProvides a comprehensive evaluation of functional balance through various static and dynamic tasks. The maximum score is 56. Higher scores indicate that good balance.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026